One-pot three-component synthesis of 1,4,5-trisubstituted 5-iodo-1,2,3-triazoles from 1-copper(I) alkyne, azide and molecular iodine

Jianlan Zhang , Wenwen Chen , Bo Wang , Zhouxing Zhao , Xinyan Wang * and Yuefei Hu *
Department of Chemistry, Tsinghua University, Beijing 100084, P. R. China. E-mail: yfh@mail.tsinghua.edu.cn; wangxinyan@mail.tsinghua.edu.cn; Fax: +86-10-62771149; Tel: +86-10-62795380

Received 8th December 2014 , Accepted 22nd January 2015

First published on 22nd January 2015


Abstract

Copper(I)-catalyzed cycloaddition of 1-iodoalkyne and azide has proven to be the most efficient method for the synthesis of 1,4,5-trisubstituted 5-iodo-1,2,3-triazoles, but pre-made 1-iodoalkyne is required. We find that the combination of 1-copper(I) alkyne and molecular iodine can serve as a synthetic equivalent of 1-iodoalkyne. Thus, the desired 5-iodo-1,2,3-triazole can be synthesized by simply mixing this combination and an azide together without the tedious synthesis of the corresponding 1-iodoalkyne.


Introduction

Great progress1 has been made in the application of 1,2,3-triazoles since the discovery of the copper(I)-catalyzed cycloaddition of azide (1) and terminal alkyne (2) (CuAAC).2 Normal CuAAC reactions produce only 1,4-disubstituted 1,2,3-triazole (3). Thus, the importance of 1,4,5-trisubstituted 5-iodo-1,2,3-triazole (4) has been enhanced recently because its iodine atom can be smoothly converted into various groups to give the corresponding 1,4,5-trisubstituted 1,2,3-triazoles, by which the diversity of structures and their properties could be increased (Fig. 1).3–8
image file: c4ra15980b-f1.tif
Fig. 1 5-Iodo-1,2,3-triazoles (4) as versatile substrates.

Investigation showed that two practical methods have been used for the synthesis of 5-iodo-1,2,3-triazoles (4) (Scheme 1). Method-a4b,6c,9 is achieved easily by adding an electrophile I+ into a normal CuAAC reaction to trap the 5-copper(I)-1,2,3-triazole intermediate. But, this method usually gives 4 as a mixture with by-product 3 caused by the competitive substitution of the in situ generated electrophile H+. Method-b4a,7a,7c,10 gives 4 as a single product by using 1-iodoalkyne (5) as a substrate under the similar conditions, but pre-made 1-iodoalkynes (5) are required.


image file: c4ra15980b-s1.tif
Scheme 1 Two practical methods for the synthesis of 4.

To date, method-b has proven to be the most efficient method for the synthesis of 5-iodo-1,2,3-triazoles (4) and a total of five protocols have been reported.4a,7a,7c,10 In these protocols, the Cu(I)-catalyzed cycloaddition of 1-iodoalkyne and azide proceeds so easily that the synthesis of the substrate 1-iodoalkyne (5) has been become a main obstacle. Herein, we would like to report a sixth protocol for the same purpose by using the combination of 1-copper(I) alkyne (6) and molecular iodine as a synthetic equivalent of 1-iodoalkyne (5). Thus, the desired 5-iodo-1,2,3-triazole (4) can be efficiently synthesized by simply mixing this combination and an azide (1) together without the tedious synthesis of the corresponding 1-iodoalkyne (5).

Results and discussion

Many protocols have been reported for the synthesis of 1-iodoalkynes (5) from terminal alkynes (2). But, only some of them could proceed under mild conditions (without using strong bases or air sensitive reagents) when the special substrates or reagents were employed.7c,11 Furthermore, since 1-iodoalkynes (5) are sensitive to air and light, decompositions are observed during their preparation, purification and storage.12 In our recent works, 1-iodoalkyne (5) was unexpectedly produced from the mixture of 1-Cu(I) alkyne (6) and NIS in CH2Cl2.13 As shown in Scheme 2, when we mixed together 1-Cu(I)-2-(4-methyphenyl)ethyne (6a) and I2 in CH2Cl2, the desired 1-iodo-2-(4-methyphenyl)ethyne (5a) was obtained also in 98% yield within 10 min.
image file: c4ra15980b-s2.tif
Scheme 2 Preparation of 1-iodoalkyne from 1-Cu(I) alkyne and I2.

Since this conversion cleanly produced equimolar amounts of 5a and CuI only, it may be used to synthesize 1-benzyl-4-(4-methylphenyl)-5-iodo-1,2,3-trizole (4a) in the presence of benzyl azide (1a). As shown in Table 1, this hypothesis was proved and 4a was obtained in 74% yield after the mixture of 1a, 6a and I2 in CH2Cl2 was stirred for 6 h (entry 1). Many solvents were suitable for this conversion and DMF gave the best results (entry 9).

Table 1 Effect of solvent on the yield of 4aa

image file: c4ra15980b-u1.tif

Entry Solvent Yieldb of 4a (%)
a The mixture of 1a (0.75 mmol), 6a (0.5 mmol) and I2 (0.5 mmol) in solvent (1 mL) was stirred in a stoppered glass tube. b The isolated yields.
1 CH2Cl2 74
2 THF 20
3 PhCH3 25
4 EtOH 43
5 CH3CN 58
6 CH3COCH3 72
7 ClCH2CH2Cl 75
8 NMP 87
9 DMF 90


Further experiments proved that the yield of 4a was influenced significantly by the reactant ratios. As shown in Table 2, the yield of 4a was increased by the increase of the ratio of 1a (entries 1–4). No comparable changes were observed by using higher ratio of 6a (entry 5–6). However, the yield of 4a was decreased sharply by the increase of the ratio of I2 (entries 7–9). Since 1,4-di(4-methylphenyl)butadiyne [(4-MePhC[triple bond, length as m-dash]C)2] was separated in these entries, the problem must be caused by the oxidizing property of I2, by which the in situ generated 1-iodoalkyne 5a underwent a Cu(I)-catalyzed oxidative coupling. The other two popular precursors of I+, NIS and ICl, were tested also under the similar conditions, but lower yields of 4a and higher yields of oxidative coupling byproduct were obtained.

Table 2 Effect of the substrate ratio on the yield of 4aa

image file: c4ra15980b-u2.tif

Entry 1a[thin space (1/6-em)]:[thin space (1/6-em)]6a[thin space (1/6-em)]:[thin space (1/6-em)]I2 (by mole) Yieldb of 4a (%)
a The mixture (0.5 mmol scale) of 1a, 6a and I2 in DMF (1 mL) was stirred in a stoppered glass tube. b The isolated yields.
1 1.0[thin space (1/6-em)]:[thin space (1/6-em)]1.0[thin space (1/6-em)]:[thin space (1/6-em)]1.0 81
2 1.2[thin space (1/6-em)]:[thin space (1/6-em)]1.0[thin space (1/6-em)]:[thin space (1/6-em)]1.0 86
3 1.5[thin space (1/6-em)]:[thin space (1/6-em)]1.0[thin space (1/6-em)]:[thin space (1/6-em)]1.0 90
4 2.0[thin space (1/6-em)]:[thin space (1/6-em)]1.0[thin space (1/6-em)]:[thin space (1/6-em)]1.0 90
5 1.5[thin space (1/6-em)]:[thin space (1/6-em)]1.2[thin space (1/6-em)]:[thin space (1/6-em)]1.0 89
6 1.5[thin space (1/6-em)]:[thin space (1/6-em)]1.5[thin space (1/6-em)]:[thin space (1/6-em)]1.0 88
7 1.5[thin space (1/6-em)]:[thin space (1/6-em)]1.0[thin space (1/6-em)]:[thin space (1/6-em)]1.2 53
8 1.5[thin space (1/6-em)]:[thin space (1/6-em)]1.0[thin space (1/6-em)]:[thin space (1/6-em)]1.5 29
9 1.5[thin space (1/6-em)]:[thin space (1/6-em)]1.0[thin space (1/6-em)]:[thin space (1/6-em)]2.0 10


In the early references, the vital role of ligand in Cu(I)-catalyzed cycloaddition of 1-iodoalkynes (5) has been reported. For example, Rutjes14 reported that the mixture of 1-iodoalkyne (5), azide (1) and CuI failed to give the cycloaddition product in the absence of ligand. But, the similar cycloaddition was reported by Fokin7c to give 5-iodo-1,2,3-triazole (4) in excellent yields in the presence of 2 equiv. of Et3N. Therefore, four popular ligands L1–L4 were tested as shown in Table 3. When 2 equiv. of Et3N (L1) were added to the reaction, 4a was obtained in 80% yield within 15 min (entry 2). The similarly efficient result was obtained also when 0.3 equiv. of Et3N (L1) was employed (entry 4). The all results in Table 3 indicated that the use of ligand could significantly enhance the reaction rate, but the yield of 4a was decreased and the coupling product (4-MePhC[triple bond, length as m-dash]C)2 was only by-product. This may result from the fact that 6a was activated by dissociating its polymeric structures with Et3N.15b–d,17a Therefore, the activated 6a underwent two by-reactions to give the by-product: (a) the oxidative coupling between two molecules of 6a; (b) the Castro–Stephens coupling between 6a and the in situ produced 5a. Finally, the entry 4 was assigned as our standard conditions.

Table 3 Effects of the ligands L1–L4 on the reactiona

image file: c4ra15980b-u3.tif

Entry L (equiv.) Time Yieldb of 4a (%)
a The mixture of 1a (0.75 mmol), 6a (0.5 mmol) and I2 (0.5 mmol) in DMF (1 mL) was stirred in a stoppered glass tube. b The isolated yields.
1 None 6 h 90
2 L1 (2.0) 15 min 80
3 L1 (0.5) 15 min 79
4 L1 (0.3) 15 min 82
5 L1 (0.2) 1.5 h 79
6 L1 (0.1) 4 h 82
7 L2 (0.3) 15 min 73
8 L3 (0.3) 1 h 70
9 L4 (0.3) 4 h 75


So far, we successfully developed a one-pot three-component method for the synthesis of 1,4,5-trisubsituted 5-iodo-1,2,3-triazoles. In fact, this similar ideal has been attempted by Fokin,7c but it failed possibly because the catalytically active complex was disrupted either through oxidation of the metal or displacement/destruction of the ligand. However, there were no such problems in our method for three possible reasons. (a) Molecular iodine (a weak electrophile with the lowest oxidizability) was used as the resource of I+ because 1-Cu(I) alkyne (6) has strong nucleophilicity. (b) A clean metathesis between 1-Cu(I) alkyne (6) and I2 occurred without use of any additive and formation of any waster, in which the quantitatively formed 1-iodoalkyne (5) and CuI are the essential substrate and catalyst, respectively. (c) The in situ formed stoichiometric amount of Cu(I) was used as a catalyst, by which the catalytic cycle of Cu(I) was unnecessary.

Thus, the success of our method is mainly due to the use of 1-Cu(I)-alkyne (6) as a substrate. It is well known that most 1-Cu(I)-alkyne (6) can be easily prepared as yellow crystals within 1 h (ref. 15, 16d and 17b) and can be stored in air for years without notable decomposition.15–17 Therefore, it is synthetically convenient and valuable to use the combination of 1-Cu(I)-alkyne (6) and I2 as a synthetic equivalent of 1-iodoalkyne (5), by which no needs of preparation, purification and storage of 1-iodoalkyne (5).

Finally, the scope of substrates and products were tested to generalize this method. As shown in Scheme 3, two yields obtained from two different procedures were reported for each product to meet the different needs. Most products were synthesized in good to excellent yields by both procedures. Compared with the procedure with ligand, the ligand-free procedure gave the higher yields, but the longer reaction time was required. The product 4q was obtained in the lowest yield may be caused by its poor solubility. It quickly crystallized from DMF once it formed even though the double amounts of DMF were used, by which some of unreacted 1-Cu(I)-alkynes (6h) were wrapped.


image file: c4ra15980b-s3.tif
Scheme 3 The scope of the method.

Conclusions

A “one-pot” three-component method for the synthesis of 1,4,5-trisubsituted 5-iodo-1,2,3-triazoles was developed from 1-Cu(I) alkyne, azide and I2. In this method, the combination of 1-Cu(I) alkyne and I2 is well served as a synthetic equivalent of 1-iodoalkyne without need of tedious preparation, purification and storage of 1-iodoalkyne.

Experimental

General information

All melting points were determined on a Yanaco melting point apparatus and were uncorrected. IR spectra were recorded as KBr pellets on a Nicolet FT-IR 5DX spectrometer. All spectra of 1H NMR (400 MHz) and 13C NMR (100 MHz) were recorded on a JEOL JNM-ECA 400 spectrometer in CDCl3 (otherwise as indicated). TMS was used as an internal reference and J values are given in Hz. HRMS were obtained on a Bruker micrOTOF-Q II spectrometer. Copper(I) alkynes 6a–6k were prepared by reported procedure in literature.15,16d,17b
A typical procedure for the preparation of 1-benzyl-4-(4-methylphenyl)-5-iodo-1,2,3-triazole (4a). Procedure A with a ligand. To a stirred suspension of 1-copper(I)-2-(4-methyl-phenyl)ethyne (6a, 89.4 mg, 0.5 mmol) in DMF (1 mL) in a glass tube was added BnN3 (1a, 99.9 mg, 0.75 mmol), I2 (126.9 mg, 0.5 mmol) and Et3N (15.2 mg, 0.15 mmol) successively at room temperature. After 15 min, the resultant mixture was subjected to a flash chromatography [silica gel, 10% EtOAc in petroleum ether (60–90 °C)] to give 153 mg (82%) of product 4a as a white solid.
Procedure B without a ligand. To a stirred suspension of copper(I)-2-(4-methylphenyl)ethyne (6a, 89.4 mg, 0.5 mmol) in DMF (1 mL) in a glass tube was added BnN3 (1a, 99.9 mg, 0.75 mmol) and I2 (126.9 mg, 0.5 mmol) successively at room temperature. After 6 h [the end-point was indicated by the fact that the in situ generated (4-methylphenyl)ethynyl iodide (5a) was exhausted], the resultant mixture was subjected to a flash chromatography [silica gel, 10% EtOAc in petroleum ether (60–90 °C)] to give 167 mg (90%) of product 4a as a white solid, mp 110–112 °C (lit.7c 119–120 °C). 1H NMR (400 MHz, CDCl3) δ 7.83 (d, J = 8.2 Hz, 2H), 7.38–7.29 (m, 5H), 7.26 (d, J = 7.8 Hz, 2H), 5.66 (s, 2H), 2.39 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 150.2, 138.5, 134.3, 129.2 (2C), 128.8 (2C), 128.4, 127.8 (2C), 127.3 (3C), 76.1, 54.3, 21.3.

The products 4b–4v were prepared similarly by this procedure.

1-Benzyl-4-(2-methylphenyl)-5-iodo-1,2,3-triazole (4b). Light yellow solid (124 mg, 66%), mp 108–110 °C. IR v 3028, 2950, 2856, 1607, 1502, 1458, 1217 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.40–7.29 (m, 8H), 7.25–7.22 (m, 1H), 5.66 (s, 2H), 2.29 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 152.2, 137.7, 134.4, 130.6, 130.5, 129.8, 129.2, 129.0 (2C), 128.6, 127.9 (2C), 125.5, 79.7, 54.4, 20.3. HRMS (ESI-TOF) (m/z): calcd for C16H14IN3, [M + H]+ 376.0305; found 376.0293.
1-Benzyl-4-(4-methoxyphenyl)-5-iodo-1,2,3-triazole (4c). White solid (139 mg, 71%), mp 116–118 °C (lit.18 114–115 °C). 1H NMR (400 MHz, CDCl3) δ 7.87 (d, J = 7.3 Hz, 2H), 7.36–7.29 (m, 5H), 6.98 (d, J = 7.4 Hz, 2H), 5.65 (s, 2H), 3.84 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 159.8, 150.1, 134.4, 128.8 (2C), 128.7 (2C), 128.4, 127.8 (2C), 122.7, 113.9 (2C), 75.6, 55.3, 54.3.
1-Benzyl-4-phenyl-5-iodo-1,2,3-triazole (4d). White solid (144 mg, 80%), mp 136–138 °C (lit.8a 138.7–140.3 °C). 1H NMR (400 MHz, CDCl3) δ 7.94 (d, J = 7.8 Hz, 2H), 7.45–7.30 (m, 8H), 5.67 (s, 2H); 13C NMR (100 MHz, CDCl3) δ 150.1, 134.3, 130.2, 128.9 (2C), 128.6, 128.5 (2C), 128.4, 127.8 (2C), 127.4 (2C), 76.4, 54.3.
1-Benzyl-4-(4-fluorophenyl)-5-iodo-1,2,3-triazole (4e). White solid (154 mg, 81%), mp 142–143 °C (lit.8a 150.8–152.0 °C). 1H NMR (400 MHz, CDCl3) δ 7.93–7.90 (m, 2H), 7.39–7.30 (m, 5H), 7.16–7.12 (m, 2H), 5.66 (s, 2H); 13C NMR (100 MHz, CDCl3) δ 162.9 (d, JCF = 247.9 Hz), 149.4, 134.2, 129.3 (d, JCF = 8.6 Hz, 2C), 128.9 (2C), 128.5, 127.8 (2C), 126.3, 115.5 (d, JCF = 21.0 Hz, 2C), 76.2, 54.4.
1-Benzyl-4-(4-chlorophenyl)-5-iodo-1,2,3-triazole (4f). White solid (168 mg, 85%), mp 135–137 °C (lit.7b no melting point was reported). 1H NMR (400 MHz, CDCl3) δ 7.89 (d, J = 8.7 Hz, 2H), 7.42 (d, J = 8.7 Hz, 2H), 7.39–7.30 (m, 5H), 5.66 (s, 2H); 13C NMR (100 MHz, CDCl3) δ 149.1, 134.5, 134.1, 128.9 (2C), 128.8 (2C), 128.7, 128.6 (2C), 128.5, 127.8 (2C), 76.4, 54.4.
1-Benzyl-4-(4-bromophenyl)-5-iodo-1,2,3-triazole (4g). White solid (194 mg, 88%), mp 136–138 °C (lit.7b no melting point was reported). 1H NMR (400 MHz, CDCl3) δ 7.83 (d, J = 8.7 Hz, 2H), 7.58 (d, J = 8.7 Hz, 2H), 7.39–7.30 (m, 5H), 5.66 (s, 2H); 13C NMR (100 MHz, CDCl3) δ 149.2, 134.1, 131.7 (2C), 129.1, 128.9 (2C), 128.8 (2C), 128.5, 127.8 (2C), 127.7, 76.4, 54.4.
1-Benzyl-4-(4-nitrophenyl)-5-iodo-1,2,3-triazole (4h). Yellow solid (162 mg, 80%), mp 126–128 °C. IR v 3042, 1595, 1514, 1451, 1340 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.31 (d, J = 9.2 Hz, 2H), 8.20 (d, J = 9.2 Hz, 2H), 7.40–7.32 (m, 5H), 5.70 (s, 2H); 13C NMR (100 MHz, CDCl3) δ 147.9, 147.5, 136.5, 133.8, 129.0 (2C), 128.7, 127.8 (2C), 127.7 (2C), 123.8 (2C), 77.7, 54.6. HRMS (ESI-TOF) (m/z): calcd for C15H11IN4O2, [M + H]+ 407.0000; found 407.0002.
1-Benzyl-5-iodo-1,2,3-triazole-4-carboxylic acid ethyl ester (4i). White solid (148 mg, 83%), mp 141–143 °C (lit.10 no melting point was reported). 1H NMR (400 MHz, CDCl3) δ 7.35–7.33 (m, 3H), 7.28–7.26 (m, 2H), 5.67 (s, 2H), 4.44 (q, J = 7.3 Hz, 2H), 1.43 (t, J = 7.3 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 160.2, 142.2, 133.5, 128.9 (2C), 128.7, 127.8 (2C), 84.6, 61.5, 54.4, 14.2.
1-Benzyl-4-cyclohexyl-5-iodo-1,2,3-triazole (4j). Light yellow solid (171 mg, 93%), mp 104–106 °C. IR v 3032, 2929, 2848, 1608, 1492, 1442, 1215 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.35–7.30 (m, 3H), 7.28–7.23 (m, 2H), 5.56 (s, 2H), 2.64–2.56 (m, 1H), 1.86–1.81 (m, 4H), 1.75–1.67 (m, 3H), 1.41–1.26 (m, 3H); 13C NMR (100 MHz, CDCl3) δ 156.0, 134.6, 128.8 (2C), 128.3, 127.7 (2C), 76.9, 53.9, 36.0, 31.9 (2C), 26.4 (2C), 25.8. HRMS (ESI-TOF) (m/z): calcd for C15H18IN3, [M + H]+ 368.0618; found 368.0613.
1-Benzyl-4-cyclopropyl-5-iodo-1,2,3-triazole (4k). Light yellow solid (145 mg, 89%), mp 103–105 °C (lit.7c 114–116 °C). 1H NMR (400 MHz, CDCl3) δ 7.36–7.30 (m, 3H), 7.29–7.24 (m, 2H), 5.54 (s, 2H), 1.80–1.74 (m, 1H), 1.06–1.02 (m, 2H), 1.00–0.94 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 153.2, 134.5, 128.8 (2C), 128.3, 127.7 (2C), 77.6, 54.0, 7.5 (2C), 7.2.
1-(4-Methylbenzyl)-4-(4-fluorophenyl)-5-iodo-1,2,3-triazole (4l). Light yellow solid (138 mg, 70%), mp 170–172 °C. IR v 3029, 2924, 2852, 1604, 1530, 1472, 1229 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.92–7.89 (m, 2H), 7.23–7.11 (m, 6H), 5.62 (s, 2H), 2.33 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 162.8 (d, JCF = 247.0 Hz), 149.4, 138.4, 131.2, 129.5 (2C), 129.3 (d, JCF = 8.6 Hz, 2C), 127.8 (2C), 126.4, 115.5 (d, JCF = 21.0 Hz, 2C), 76.1, 54.2, 21.1. HRMS (ESI-TOF) (m/z): calcd for C16H13FIN3, [M + H]+ 394.0211; found 394.0207.
1-(4-Fluorobenzyl)-4-(4-methylphenyl)-5-iodo-1,2,3-triazole (4m). Light yellow solid (161 mg, 82%), mp 128–130 °C. IR v 3036, 2918, 2860, 1605, 1506, 1471, 1222 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.82 (d, J = 8.2 Hz, 2H), 7.33–7.25 (m, 4H), 7.06–7.01 (m, 2H), 5.62 (s, 2H), 2.39 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 162.7 (d, JCF = 245.7 Hz), 150.3, 138.6, 130.1 (d, JCF = 3.8 Hz), 129.8 (d, JCF = 8.4 Hz, 2C), 129.2 (2C), 127.3 (2C), 127.2, 115.9 (d, JCF = 22.1 Hz, 2C), 75.9, 53.6, 21.3. HRMS (ESI-TOF) (m/z): calcd for C16H13FIN3, [M + H]+ 394.0211; found 394.0206.
1-(4-Bromobenzyl)-4-(4-methylphenyl)-5-iodo-1,2,3-triazole (4n). Light yellow solid (177 mg, 78%), mp 157–159 °C. IR v 3027, 2935, 2856, 1584, 1478, 1228 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.81 (d, J = 7.8 Hz, 2H), 7.48 (d, J = 8.2 Hz, 2H), 7.26 (d, J = 8.2 Hz, 2H), 7.18 (d, J = 8.2 Hz, 2H), 5.60 (s, 2H), 2.39 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 150.4, 138.6, 133.3, 132.1 (2C), 129.5 (2C), 129.2 (2C), 127.3 (2C), 127.1, 122.6, 76.0, 53.7, 21.3. HRMS (ESI-TOF) (m/z): calculated for C16H13BrIN3, [M + H]+ 453.9410; found 453.9408.
1-(4-Methoxylbenzyl)-4-(4-methylphenyl)-5-iodo-1,2,3-triazole (4o). White solid (152 mg, 75%), mp 121–123 °C. IR v 3015, 2929, 2840, 1610, 1510, 1442, 1245 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.81 (d, J = 7.4 Hz, 2H), 7.29–7.24 (m, 4H), 6.86 (d, J = 7.8 Hz, 2H), 5.57 (s, 2H), 3.78 (s, 3H), 2.38 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 159.6, 150.2, 138.4, 129.4 (2C), 129.1 (2C), 127.3, 127.2 (2C), 126.4, 114.2 (2C), 75.8, 55.2, 53.9, 21.3. HRMS (ESI-TOF) (m/z): calculated for C17H16IN3O, [M + H]+ 406.0411; found 406.0403.
1-(4-Methylbenzyl)-4-(4-methylphenyl)-5-iodo-1,2,3-triazole (4p). Light yellow solid (169 mg, 87%), mp 116–118 °C. IR v 3026, 2917, 2860, 1615, 1510, 1472, 1222 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.82 (d, J = 8.2 Hz, 2H), 7.26–7.14 (m, 6H), 5.61 (s, 2H), 2.39 (s, 3H), 2.33 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 150.2, 138.4, 138.3, 131.3, 129.5 (2C), 129.2 (2C), 127.8 (2C), 127.3, 127.2 (2C), 76.0, 54.1, 21.3, 21.1. HRMS (ESI-TOF) (m/z): calcd for C17H16IN3, [M + H]+ 390.0462; found 390.0463.
1-(4-Nitrobenzyl)-4-(4-methylphenyl)-5-iodo-1,2,3-triazole (4q). Light yellow solid (84 mg, 40%), mp 190–192 °C. IR v 3020, 2920, 2860, 1607, 1535, 1346, 1224 cm−1; 1H NMR (400 MHz, DMSO-d6) δ 8.26 (d, J = 8.7 Hz, 2H), 7.80 (d, J = 8.2 Hz, 2H), 7.46 (d, J = 8.7 Hz, 2H), 7.31 (d, J = 8.2 Hz, 2H), 5.91 (s, 2H), 2.35 (s, 3H); 13C NMR (100 MHz, DMSO-d6) δ 150.2, 148.1, 143.8, 138.8, 130.1 (2C), 129.4 (2C), 128.4, 127.7 (2C), 124.9 (2C), 82.6, 53.7, 21.8. HRMS (ESI-TOF) (m/z): calcd for C16H13IN4O2, [M + H]+ 421.0156; found 421.0152.
1-(2-Naphthylmethyl)-4-(4-methylphenyl)-5-iodo-1,2,3-triazole (4r). White solid (119 mg, 56%), mp 154–156 °C. IR v 3049, 2922, 2860, 1726, 1507, 1437, 1227 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.85–7.78 (m, 5H), 7.73 (s, 1H), 7.50–7.46 (m, 2H), 7.41 (d, J = 8.2 Hz, 1H), 7.25 (d, J = 7.8 Hz, 2H), 5.80 (s, 2H), 2.38 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 150.3, 138.5 (2C), 133.1, 133.0, 131.7, 129.2, 128.8, 127.9, 127.7, 127.3 (3C), 127.1, 126.5, 126.4, 125.1, 76.1, 54.5, 21.3. HRMS (ESI-TOF) (m/z): calcd for C20H16IN3, [M + H]+ 426.0462; found 426.0458.
1-(α-Methylbenzyl)-4-(4-methylphenyl)-5-iodo-1,2,3-triazole (4s). White solid (88 mg, 45%), mp 144–146 °C. IR v 3023, 2994, 2931, 2861, 1611, 1480, 1448, 1217 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.81 (d, J = 7.8 Hz, 2H), 7.36–7.29 (m, 5H), 7.26–7.24 (m, 2H), 5.78 (q, J = 7.2 Hz, 1H), 2.38 (s, 3H), 2.10 (d, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 149.7, 140.2, 138.4, 129.1 (2C), 128.8 (2C), 128.2, 127.5 (2C), 127.4, 126.6 (2C), 76.6, 61.4, 22.3, 21.3. HRMS (ESI-TOF) (m/z): calcd for C17H16IN3, [M + H]+ 390.0462; found 390.0466.
1-(Oct-1-yl)-4-(4-methylphenyl)-5-iodo-1,2,3-triazole (4t). Light yellow solid (179 mg, 90%), mp 72–74 °C. IR v 3038, 2920, 2856, 1641, 1510, 1460, 1225 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.82 (d, J = 7.8 Hz, 2H), 7.27 (d, J = 7.8 Hz, 2H), 4.42 (t, J = 7.3 Hz, 2H), 2.40 (s, 3H), 1.98–1.91 (m, 2H), 1.38–1.28 (m, 10H), 0.88 (t, J = 6.9 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 149.7, 138.3, 129.2 (2C), 127.5, 127.3 (2C), 75.8, 50.9, 31.7, 29.9, 29.0, 28.9, 26.4, 22.6, 21.3, 14.0. HRMS (ESI-TOF) (m/z): calcd for C17H24IN3, [M + H]+ 398.1088; found 398.1085.
1-(3-Methylbut-1-yl)-4-(4-methylphenyl)-5-iodo-1,2,3-triazole (4u). White solid (163 mg, 92%), mp 83–85 °C. IR v 3035, 2950, 2920, 2861, 1641, 1514, 1460, 1255 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.81 (d, J = 7.8 Hz, 2H), 7.27 (d, J = 7.8 Hz, 2H), 4.44 (t, J = 7.8 Hz, 2H), 2.40 (s, 3H), 1.84 (q, J = 6.9 Hz, 2H), 1.73–1.66 (m, 1H), 1.01 (d, J = 8.3 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 149.7, 138.3, 129.2, 127.5 (2C), 127.3 (2C), 76.7, 49.4, 38.6, 25.6, 22.3 (2C), 21.3. HRMS (ESI-TOF) (m/z): calcd for C14H18IN3, [M + H]+ 356.0618; found 356.0616.
1-Cycylohexyl-4-(4-methylphenyl)-5-iodo-1,2,3-triazole (4v). Light yellow solid (138 mg, 75%), mp 156–158 °C. IR v 3035, 2923, 2853, 1611, 1510, 1450, 1225 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.81 (d, J = 7.8 Hz, 2H), 7.26 (d, J = 7.8 Hz, 2H), 4.41–4.34 (m, 1H), 2.39 (s, 3H), 2.12–1.95 (m, 6H), 1.79–1.76 (m, 1H), 1.52–1.26 (m, 3H); 13C NMR (100 MHz, CDCl3) δ 149.1, 138.2, 129.1 (2C), 127.6, 127.5 (2C), 75.8, 61.1, 32.7 (2C), 25.4 (2C), 25.0, 21.3. HRMS (ESI-TOF) (m/z): calcd for C15H18IN3, [M + H]+ 368.0618; found 368.0618.

Acknowledgements

This work was supported by the National Natural Scientific Foundation of China (nos 21472107, 21372142 and 21072112).

Notes and references

  1. For selected reviews, see: (a) N. V. Sokolova and V. G. Nenajdenko, RSC Adv., 2013, 3, 16212–16242 RSC; (b) Applications of click chemistry themed issue (guest ed. M. G. Finn and V. V. Fokin), Chem. Soc. Rev., 2010, 39, 1231–1405; (c) M. Meldal and C. W. Tornøe, Chem. Rev., 2008, 108, 2952–3015 CrossRef CAS PubMed; (d) V. D. Bock, H. Hiemstra and J. H. van Maarseveen, Eur. J. Org. Chem., 2006, 51–68 CrossRef CAS.
  2. (a) V. V. Rostovtsev, L. G. Green, V. V. Fokin and K. B. Sharpless, Angew. Chem., Int. Ed., 2002, 41, 2596–2599 CrossRef CAS; (b) C. Tornøe, C. Christensen and M. Meldal, J. Org. Chem., 2002, 67, 3057–3064 CrossRef PubMed.
  3. (a) J. M. Schulman, A. A. Friedman, J. Panteleev and M. Lautens, Chem. Commun., 2012, 48, 55–57 RSC; (b) M. Juricek, K. Stout, P. H. J. Kouwer and A. E. Rowan, Org. Lett., 2011, 13, 3494–3497 CrossRef CAS PubMed; (c) J. Panteleev, K. Geyer, A. Aguilar-Aguilar, L. Wang and M. Lautens, Org. Lett., 2010, 12, 5092–5095 CrossRef CAS PubMed.
  4. (a) J. S. Oakdale, R. K. Sit and V. V. Fokin, Chem.–Eur. J., 2014, 20, 11101–11110 CrossRef CAS PubMed; (b) Y.-M. Wu, J. Deng, Y. Li and Q.-Y. Chen, Synthesis, 2005, 1314–1318 CrossRef CAS.
  5. (a) E. Schwartz, K. Breitenkamp and V. V. Fokin, Macromolecules, 2011, 44, 4735–4741 CrossRef CAS; (b) A. Bogdan and K. James, Org. Lett., 2011, 13, 4060–4063 CrossRef CAS PubMed; (c) J. Deng, Y.-M. Wu and Q.-Y. Chen, Synthesis, 2005, 2730–2738 CAS.
  6. (a) J. C. Morris, J. Chiche, C. Grellier, M. Lopez, L. F. Bornaghi, A. Maresca, C. T. Supuran, J. Pouyssegur and S.-A. Poulsen, J. Med. Chem., 2011, 54, 6905–6918 CrossRef CAS PubMed; (b) T. Ostrowski, P. Januszczyk, M. Cieslak, J. Kazmierczak-Baranska, B. Nawrot, E. Bartoszak-Adamska and J. Zeidler, Bioorg. Med. Chem., 2011, 19, 4386–4398 CrossRef CAS PubMed; (c) V. Malnuit, M. Duca, A. Manout, K. Bougrin and R. Benhida, Synlett, 2009, 2123–2128 CAS; (d) N. Joubert, R. F. Schinazi and L. A. Agrofoglio, Tetrahedron, 2005, 61, 11744–11750 CrossRef CAS PubMed.
  7. (a) J. García-Álvarez, J. Diez, J. Gimeno, F. J. Suarez and C. Vincent, Eur. J. Inorg. Chem., 2012, 5854–5863 CrossRef; (b) P. Diner, T. Andersson, J. Kjellen, K. Elbing, S. Hohmann and M. Groli, New J. Chem., 2009, 33, 1010–1016 RSC; (c) J. E. Hein, J. C. Tripp, L. B. Krasnova, K. B. Sharpless and V. V. Fokin, Angew. Chem., Int. Ed., 2009, 48, 8018–8021 CrossRef CAS PubMed.
  8. (a) D. Fu, J. Zhang and S. Cao, J. Fluorine Chem., 2013, 156, 170–176 CrossRef CAS PubMed; (b) B. T. Worrell, J. E. Hein and V. V. Fokin, Angew. Chem., Int. Ed., 2012, 51, 11791–11794 CrossRef CAS PubMed.
  9. (a) W. S. Brotherton, R. J. Clark and L. Zhu, J. Org. Chem., 2012, 77, 6443–6455 CrossRef CAS PubMed; (b) N. W. Smith, B. P. Polenz, S. B. Johnson and S. V. Dzyuba, Tetrahedron Lett., 2010, 51, 550–553 CrossRef CAS PubMed; (c) L. Li, G. Zhang, A. Zhu and L. Zhang, J. Org. Chem., 2008, 73, 3630–3633 CrossRef CAS PubMed.
  10. (a) C. Vidal and J. García-Álvarez, Green Chem., 2014, 16, 3515–3521 RSC; (b) J. Garcia-Álvarez, J. Diez and J. Gimeno, Green Chem., 2010, 12, 2127–2130 RSC.
  11. (a) M. Nouzarian, R. Hosseinzadeh and H. Golchoubian, Synth. Commun., 2013, 43, 2913–2925 CrossRef CAS; (b) P. Starkov, F. Rota, J. M. D'Oyley and T. D. Sheppard, Adv. Synth. Catal., 2012, 354, 3217–3224 CrossRef CAS; (c) K. R. Reddy, M. Venkateshwar, C. U. Maheswari and P. S. Kumar, Tetrahedron Lett., 2010, 51, 2170–2173 CrossRef PubMed; (d) J. Yan, J. Li and D. Cheng, Synlett, 2007, 2442–2444 CrossRef CAS PubMed; (e) G. W. Kabalka and A. R. Mereddy, Tetrahedron Lett., 2004, 45, 1417–1419 CrossRef CAS PubMed; (f) F. Homsi and G. Rousseau, Tetrahedron Lett., 1999, 40, 1495–1498 CrossRef CAS; (g) H. Monenschein, G. Sourkouni-Argirusi, K. M. Schubothe, T. O'Hare and A. Kirschning, Org. Lett., 1999, 1, 2101–2104 CrossRef CAS; (h) D. Naskar and S. Roy, J. Org. Chem., 1999, 64, 6896–6897 CrossRef CAS; (i) Y. Brunel and G. Rousseau, Tetrahedron Lett., 1995, 36, 2619–2622 CrossRef CAS; (j) T. Jeffery, J. Chem. Soc., Chem. Commun., 1988, 909–910 RSC.
  12. G. Pelletier, S. Lie, J. J. Mousseau and A. B. Charette, Org. Lett., 2012, 14, 5464–5467 CrossRef CAS PubMed , The decomposition of 1-iodoalkynes was studied and a special note was gaven in SI (pp S12–S13) of this article: “Note: The synthesized 1-iodoalkynes were found usually unstable to light exposure and trace of iodine is observed when the product is solubilized or purified by flash chromatography (a pink color gradually appears when flashed or stored on the bench at room temperature). They should be kept under argon in the freezer (–20 °C) or use directly in a further reaction.”.
  13. B. Wang, J. Zhang, X. Wang, N. Liu, W. Chen and Y. Hu, J. Org. Chem., 2013, 78, 10519–10523 CrossRef CAS PubMed.
  14. B. H. M. Kuijpers, G. C. T. Dijkmans, S. Groothuys, P. J. L. M. Quaedflieg, R. H. Blaauw, F. L. van Delft and F. P. J. T. Rutjes, Synlett, 2005, 3059–3062 CAS.
  15. (a) E. C. Y. Woon, A. Dhami, M. F. Mahon and M. D. Threadgill, Tetrahedron, 2006, 62, 4829–4837 CrossRef CAS PubMed; (b) D. C. Owsley and C. E. Castro, Org. Synth., 1972, 52, 128–130 CrossRef CAS; (c) C. E. Castro, R. Havlin, V. K. Honwad, A. Malte and S. Moje, J. Am. Chem. Soc., 1969, 91, 6464–6470 CrossRef CAS; (d) R. D. Stephens and C. E. Castro, J. Org. Chem., 1963, 28, 3313–3315 CrossRef CAS.
  16. Recent works on 1-Cu(I) alkynes: (a) K. Jouvin, R. Veillard, C. Theunissen, C. Alayrac, A.-C. Gaumont and G. Evano, Org. Lett., 2013, 15, 4592–4595 CrossRef CAS PubMed; (b) F. Verna, C. Guissart, J. Pous and G. Evano, Monatsh. Chem., 2013, 144, 523–529 CrossRef CAS; (c) A. Laouiti, K. Jouvin, F. Bourdreux, M. M. Rammah, M. B. Rammah and G. Evano, Synthesis, 2012, 44, 1491–1500 CrossRef CAS PubMed; (d) K. Jouvin, J. Heimburger and G. Evano, Chem. Sci., 2012, 3, 756–760 RSC; (e) B. R. Buckley, S. E. Dann, H. Heaney and E. C. Stubbs, Eur. J. Org. Chem., 2011, 770–776 CrossRef CAS.
  17. Our recent works on 1-Cu(I) alkynes, see: ref. 13 and (a) B. Wang, N. Liu, W. Chen, D. Huang, X. Wang and Y. Hu, Adv. Synth. Catal., 2015, 357 DOI:10.1002/adsc.201400471 , ASAP; (b) W. Chen, B. Wang, N. Liu, D. Huang, X. Wang and Y. Hu, Org. Lett., 2014, 16, 6140–6143 CrossRef CAS PubMed; (c) B. Wang, M. N. Ahmed, J. Zhang, W. Chen, X. Wang and Y. Hu, Tetrahedron Lett., 2013, 54, 6097–6100 CrossRef CAS PubMed; (d) B. Wang, N. Liu, C. Shao, Q. Zhang, X. Wang and Y. Hu, Adv. Synth. Catal., 2013, 355, 2564–2568 CrossRef CAS.
  18. L. Li, G. Hao, A. Zhu, S. Liu and G. Zhang, Tetrahedron Lett., 2013, 54, 6057–6060 CrossRef CAS PubMed.

Footnote

Electronic supplementary information (ESI) available: 1H and 13C NMR spectra for products 4a–4v. See DOI: 10.1039/c4ra15980b

This journal is © The Royal Society of Chemistry 2015
Click here to see how this site uses Cookies. View our privacy policy here.